Regional Observatory on Metabolic Syndrome- LAZIO

Completed

• Conditions: Metabolic Syndrome

• Registration Number: NCT00689455
• Lead Sponsor: AstraZeneca

Brief Summary

The aim of the study, is to assess the prevalence of Metabolic Syndrome in Italy on a regional basis, defined according to NCEP/ATPIII Guidelines criteria.

Detailed Description

Not available

Study Timeline

• Study Start: 2007-10
• Study First Submitted: 2008-05-29
• Study First Submitted QC: 2008-06-02
• Study First Posted: 2008-06-03
• Primary Completion: 2008-12
• Study Completion: 2008-12
• Status Verified: 2010-12
• Last Update Submitted: 2010-12-02
• Last Update Posted: 2010-12-03

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1574

Inclusion Criteria

• lipid profile in the last year
• Signed informed consent

Read More

Exclusion Criteria

• Subjects with serious or unstable medical or psychological conditions that, in the opinion of the investigator, would compromise the subject's successful participation in the study
• Pregnancy or breast feeding
• Subject who are unwilling or unable to provide the informed consent

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Prevalence of Metabolic Syndrome in Primary Care Population.	At Visit

Secondary Outcome Measures

Name	Time	Method
Concomitant presence of other CV risk factors.	At Visit

Trial Locations

Locations (1)

Research Site; 🇮🇹 Viterbo, Italy